ProQR Therapeutics NV (PRQR)
3.62
+0.01
(+0.28%)
USD |
NASDAQ |
Nov 22, 16:00
3.63
+0.01
(+0.28%)
After-Hours: 20:00
ProQR Therapeutics Enterprise Value: 288.57M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 288.57M |
| November 21, 2024 | 287.51M |
| November 20, 2024 | 293.86M |
| November 19, 2024 | 286.45M |
| November 18, 2024 | 291.75M |
| November 15, 2024 | 309.75M |
| November 14, 2024 | 323.52M |
| November 13, 2024 | 324.58M |
| November 12, 2024 | 326.69M |
| November 11, 2024 | 324.58M |
| November 08, 2024 | 304.45M |
| November 07, 2024 | 283.27M |
| November 06, 2024 | 290.69M |
| November 05, 2024 | 284.33M |
| November 04, 2024 | 289.63M |
| November 01, 2024 | 300.22M |
| October 31, 2024 | 275.86M |
| October 30, 2024 | 282.92M |
| October 29, 2024 | 261.25M |
| October 28, 2024 | 246.80M |
| October 25, 2024 | 262.28M |
| October 24, 2024 | 249.09M |
| October 23, 2024 | 190.26M |
| October 22, 2024 | 213.95M |
| October 21, 2024 | 236.00M |
| Date | Value |
|---|---|
| October 18, 2024 | 258.87M |
| October 17, 2024 | 271.94M |
| October 16, 2024 | 233.55M |
| October 15, 2024 | 53.03M |
| October 14, 2024 | 53.03M |
| October 11, 2024 | 56.30M |
| October 10, 2024 | 58.75M |
| October 09, 2024 | 57.93M |
| October 08, 2024 | 57.93M |
| October 07, 2024 | 64.47M |
| October 04, 2024 | 64.47M |
| October 03, 2024 | 53.85M |
| October 02, 2024 | 58.75M |
| October 01, 2024 | 48.95M |
| September 30, 2024 | 53.85M |
| September 27, 2024 | 51.16M |
| September 26, 2024 | 47.08M |
| September 25, 2024 | 48.71M |
| September 24, 2024 | 38.91M |
| September 23, 2024 | 38.91M |
| September 20, 2024 | 43.00M |
| September 19, 2024 | 47.08M |
| September 18, 2024 | 48.71M |
| September 17, 2024 | 51.16M |
| September 16, 2024 | 51.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-99.27M
Minimum
Mar 25 2022
448.31M
Maximum
Dec 16 2019
125.66M
Average
116.72M
Median
Nov 19 2020
Enterprise Value Benchmarks
| uniQure NV | -102.39M |
| Merus NV | 2.482B |
| argenx SE | 33.13B |
| Pharming Group | 434.45M |
| Pharvaris NV | 867.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.917M |
| Revenue (Quarterly) | 4.227M |
| Total Expenses (Quarterly) | 13.96M |
| EPS Diluted (Quarterly) | -0.11 |
| Profit Margin (Quarterly) | -211.0% |
| Earnings Yield | -8.71% |
| Normalized Earnings Yield | -9.441 |